BUZZ-Valeant Pharmaceuticals International Inc: CEO says on road to recovery
** Canadian drugmaker's U.S.-listed shares up 6 pct at $93.72
** Ailing Chief Executive, Michael Pearson, said he was on road to recovery but was uncertain when he would return from medical leave
** Pearson's illness capped a tumultuous year for Valeant as investors turned up pressure for Canadian drugmaker to provide more detailed plan on how it will increase profits in 2016
** Company also said FDA had accepted marketing application filed by partner AstraZeneca Plc for brodalumab injection, to treat patients with moderate-to-severe plaque psoriasis
** Valeant's stock had fallen 29 pct in 2015
© Thomson Reuters 2017 All rights reserved.